Kato J, Namikawa K, Uehara J, Nomura M, et al. Prognoses of melanoma patients who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: A multicenter retrospective study. Br J Dermatol 2022 Mar 29. doi: 10.1111/bjd.21276.
PMID: 35347707